Intervacc

1,14 SEK

-0,70%

Mindre end 1K følgere

IVACC

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Kvartalsdata

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Intervacc

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Omsætning2,54,111,84,67,05,43,120,1
EBITDA-17,9-14,0-58,8-8,9-14,0-10,3-31,7-64,9
EBIT-22,5-18,5-77,3-13,5-18,6-15,0-36,4-83,5
EBIT-%-889,7 %-448,2 %-655,5 %-296,3 %-265,5 %-278,5 %-1.164,8 %-415,7 %
Overskud før skat-22,2-18,1-75,5-13,2-17,8-14,3-35,6-80,8
Netto indkomst-22,2-18,1-75,5-13,2-17,8-14,3-35,6-80,8